Phase 3 Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to take part voluntarily and sign a consent form
- People with a life expectancy of more than 12 weeks
- People who are fully active or have only minor restrictions in daily physical activity (as measured by a standard medical scoring system called ECOG, at level 0 or 1)
- People who have been confirmed through a tissue test to have stomach cancer or cancer at the junction of the stomach and food pipe that cannot be removed by surgery and has either spread locally or to other parts of the body
- People who have not received any previous systemic treatment for advanced or metastatic stomach cancer, or whose cancer came back or got worse at least 6 months after finishing earlier pre- or post-surgery treatment
- People whose cancer tests show high levels of a protein called HER2
- People who have at least one measurable tumour that can be assessed using standard imaging guidelines (RECIST v1.1)
- People whose liver, kidneys, and other organs are functioning well enough to meet the trial's requirements (confirm specific thresholds with trial site)
- Women of childbearing potential who have a negative blood pregnancy test within 7 days before starting treatment, and who agree not to breastfeed or donate eggs from the time of signing the consent form until 6 months after the last treatment
- Men who agree not to donate sperm from the time of signing the consent form until 6 months after the last treatment
- People who are able to understand what the study involves and are willing to follow all study and follow-up procedures
Who may not be able to join:
- People who have cancer that has spread to the brain or the lining around the brain or spinal cord
- People who have nerve damage in their hands or feet beyond a mild level (greater than Grade 1)
- People whose tumours have a tendency to bleed
- People with serious digestive system problems that may affect how a drug is taken in or absorbed by the body
- People who have bone spread of cancer that puts them at risk of paralysis
- People who have had, or currently have, scarring or inflammation in the lungs, or who have severely reduced lung function
- People who have had another type of cancer in the past 5 years, unless that cancer is considered likely to have been fully cured by treatment
- People who are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86+010-65018841
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-Free Survival (assessed by the BIRC)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.